SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001596770-16-000113
Filing Date
2016-02-16
Accepted
2016-02-16 10:28:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 REGENXBIO SCHEDULE 13G 2-11-16 schedule13g.htm SC 13G 409434
  Complete submission text file 0001596770-16-000113.txt   411148
Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650-475-3734
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89108 | Film No.: 161424294
SIC: 2836 Biological Products, (No Diagnostic Substances)